BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35192837)

  • 1. A new missense mutation of calcium sensing receptor with isoleucine replaced by serine at codon 857 leading to type V Bartter syndrome.
    Chou KJ; Hsu CY; Huang CW; Chen HJ; Ou SH; Chen CL; Lee PT; Fang HC
    Exp Cell Res; 2022 May; 414(1):113080. PubMed ID: 35192837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome.
    Vezzoli G; Arcidiacono T; Paloschi V; Terranegra A; Biasion R; Weber G; Mora S; Syren ML; Coviello D; Cusi D; Bianchi G; Soldati L
    J Nephrol; 2006; 19(4):525-8. PubMed ID: 17048213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemia.
    Letz S; Haag C; Schulze E; Frank-Raue K; Raue F; Hofner B; Mayr B; Schöfl C
    PLoS One; 2014; 9(12):e115178. PubMed ID: 25506941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome.
    Vargas-Poussou R; Huang C; Hulin P; Houillier P; Jeunemaître X; Paillard M; Planelles G; Déchaux M; Miller RT; Antignac C
    J Am Soc Nephrol; 2002 Sep; 13(9):2259-66. PubMed ID: 12191970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel compound heterozygous KCNJ1 gene mutation presenting as late-onset Bartter syndrome: Case report.
    Li J; Hu S; Nie Y; Wang R; Tan M; Li H; Zhu S
    Medicine (Baltimore); 2019 Aug; 98(34):e16738. PubMed ID: 31441846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal dominant hypocalcemia with Bartter syndrome due to a novel activating mutation of calcium sensing receptor, Y829C.
    Choi KH; Shin CH; Yang SW; Cheong HI
    Korean J Pediatr; 2015 Apr; 58(4):148-53. PubMed ID: 25932037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Calcium-Sensing Receptor (CASR) Mutation in a Family with Autosomal Dominant Hypocalcemia Type 1 (ADH1): Genetic Study over Three Generations and Clinical Characteristics.
    Zung A; Barash G; Banne E; Levine MA
    Horm Res Paediatr; 2023; 96(5):473-482. PubMed ID: 36812896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations.
    Egbuna OI; Brown EM
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):129-48. PubMed ID: 18328986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in the calcium-sensing receptor in a French family with familial hypocalciuric hypercalcaemia.
    Al-Salameh A; Cetani F; Pardi E; Vulpoi C; Pierre P; de Calan L; Guyetant S; Jeunemaitre X; Lecomte P
    Eur J Endocrinol; 2011 Aug; 165(2):359-63. PubMed ID: 21566075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and functional analysis of a novel CaSR mutation in a family with familial hypocalciuric hypercalcemia.
    Kim ES; Kim SY; Lee JY; Han JH; Sohn TS; Son HS; Moon SD
    J Bone Miner Metab; 2016 Nov; 34(6):662-667. PubMed ID: 26386835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two novel mutations of the calcium-sensing receptor gene affecting the same amino acid position lead to opposite phenotypes and reveal the importance of p.N802 on receptor activity.
    Lia-Baldini AS; Magdelaine C; Nizou A; Airault C; Salles JP; Moulin P; Delemer B; Aitouares M; Funalot B; Sturtz F; Lienhardt-Roussie A
    Eur J Endocrinol; 2013 Feb; 168(2):K27-34. PubMed ID: 23169696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-sensing receptor sequencing in 21 patients with idiopathic or familial parathyroid disorder: pitfalls and characterization of a novel I32 V loss-of-function mutation.
    Szalat A; Shahar M; Shpitzen S; Nachmias B; Munter G; Gillis D; Durst R; Mevorach D; Leitersdorf E; Meiner V; Rosen H
    Endocrine; 2015 Mar; 48(2):444-53. PubMed ID: 25091521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excessive signal transduction of gain-of-function variants of the calcium-sensing receptor (CaSR) are associated with increased ER to cytosol calcium gradient.
    Ranieri M; Tamma G; Di Mise A; Vezzoli G; Soldati L; Svelto M; Valenti G
    PLoS One; 2013; 8(11):e79113. PubMed ID: 24244430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism.
    Hannan FM; Thakker RV
    Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):359-71. PubMed ID: 23856265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation of the calcium-sensing receptor gene in a Greek family from Nisyros.
    Zapanti E; Polonifi A; Kokkinos M; Boutzios G; Kassi G; Nasiri Ansari N; Kassi E; Polyzos A
    Hormones (Athens); 2015; 14(2):321-5. PubMed ID: 26158657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914.
    Park SY; Mun HC; Eom YS; Baek HL; Jung TS; Kim CH; Hong S; Lee S
    Clin Endocrinol (Oxf); 2013 May; 78(5):687-93. PubMed ID: 23009664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia.
    Okazaki R; Chikatsu N; Nakatsu M; Takeuchi Y; Ajima M; Miki J; Fujita T; Arai M; Totsuka Y; Tanaka K; Fukumoto S
    J Clin Endocrinol Metab; 1999 Jan; 84(1):363-6. PubMed ID: 9920108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation of the primary protein kinase C phosphorylation site in the calcium-sensing receptor causes autosomal dominant hypocalcemia.
    Lazarus S; Pretorius CJ; Khafagi F; Campion KL; Brennan SC; Conigrave AD; Brown EM; Ward DT
    Eur J Endocrinol; 2011 Mar; 164(3):429-35. PubMed ID: 21135065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of gain-of-function mutation in calcium-sensing receptor: supplemental hydration is required for renal protection.
    Suzuki M; Aso T; Sato T; Michimata M; Kazama I; Saiki H; Hatano R; Ejima Y; Miyama N; Sato A; Matsubara M
    Clin Nephrol; 2005 Jun; 63(6):481-6. PubMed ID: 15960151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare diseases caused by abnormal calcium sensing and signalling.
    Tőke J; Czirják G; Enyedi P; Tóth M
    Endocrine; 2021 Mar; 71(3):611-617. PubMed ID: 33528764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.